Dechra Pharmaceuticals PLC — Director's Dealing 2013

Sep 30, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2648P

Dechra Pharmaceuticals PLC

30 September 2013

30 September 2013

Dechra Pharmaceuticals PLC

(the "Company")

Director / PDMR Shareholding

The Company announces that on 27 September 2013 Anne-Francoise Nesmes, Chief Financial Officer, was granted the following awards over ordinary shares of 1 pence each in the Company.  Each award will vest, subject to the satisfaction of a performance condition, on the date specified below. 

Type of award	Number of shares subject to award	Vesting date
Nil cost option	41,739	30 June 2014
Nil cost option	41,739	30 June 2015

These are the recruitment awards referred to in the Company's Directors' Remuneration Report for the year ended 30 June 2013. 

For further information, please contact:

Zoe Goulding, Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSNKKDKBBKDFCN